Top 10 Companies in the Medical Spunlace Nonwoven Fabric Market (2026): Market Leaders Powering Global Healthcare

MARKET INSIGHTS

Global medical spunlace nonwoven fabric market size was valued at USD 6.21 billion in 2024. The market is projected to grow from USD 6.62 billion in 2025 to USD 10.45 billion by 2032, exhibiting a compound annual growth rate of 6.7% during the forecast period. By 2034, the value is expected to reach approximately USD 12.5 billion, reflecting continued demand for high‑performance, single‑use medical textiles.

Medical spunlace nonwoven fabric is a specialized textile engineered by high‑pressure water jets that entangle fibers, creating a soft, strong, and highly absorbent material without chemical binders. The process delivers fabrics that are gentle on the skin, lint‑free, and possess excellent drapability, making them indispensable for surgical gowns, drapes, wound dressings, facial masks, and protective apparel.

Demand for these fabrics is driven by rising global hygiene requirements, heightened focus on infection prevention and control, and stringent regulatory standards for medical textiles. The COVID‑19 pandemic accelerated adoption, especially for personal protective equipment (PPE). However, raw‑material price volatility and environmental concerns around single‑use disposables present ongoing challenges. Key players such as Freudenberg Group, Ahlstrom‑Munksjö, and Berry Global continue to innovate with sustainable materials and advanced production technologies to capture market share.

Medical Spunlace Nonwoven Fabric Market – View in Detailed Research Report

Top 10 Companies in the Medical Spunlace Nonwoven Fabric Market (2026)

Below is a ranking of the leading manufacturers that shape the market, based on market presence, product innovation, and strategic initiatives.

1. Winner Medical Co., Ltd. (China)

Headquarters: Shanghai, China
Key Offering: High‑performance cotton‑based spunlace fabrics for wound dressings, surgical gowns, and protective apparel.

Winner Medical’s deep expertise in cotton spunlace positions it as a preferred supplier for applications where softness and biocompatibility are paramount. The company has recently expanded its production capacity by 30% to meet rising demand in Asia‑Pacific and Europe.

Sustainability Initiatives: Implementation of closed‑loop water recycling in hydroentanglement lines and certification of all products to ISO 14001.

• Invested USD 20 million in R&D for bio‑based fiber blends.
• Launched a digital supply‑chain transparency platform for end‑users.

2. Jacob Holm (Switzerland)

Headquarters: Zurich, Switzerland
Key Offering: Premium spunlace nonwovens under the Sontara brand for medical hygiene and industrial hygiene.

Jacob Holm’s focus on precision hydroentanglement delivers fabrics with superior barrier performance and low linting, making them ideal for surgical drapes and isolation gowns. The firm has secured long‑term contracts with several European hospital networks.

Sustainability Initiatives: Adoption of renewable energy sources for 80% of manufacturing sites.

• Partnership with EU Horizon 2020 for smart textile development.
• Launch of a circular economy program for used medical textiles.

3. ANDRITZ AG (Austria)

Headquarters: Graz, Austria
Key Offering: Hydroentanglement equipment and spunlace raw materials for medical applications.

ANDRITZ’s dual role as equipment supplier and material producer allows it to control quality end‑to‑end. The company’s recent investment in AI‑driven process monitoring has reduced fiber loss by 12%.

Sustainability Initiatives: Development of water‑free hydroentanglement technologies.

• Integrated ESG reporting aligned with GRI standards.
• Collaboration with academic partners on biodegradable fibers.

4. Mogul Nonwovens (Turkey)

Headquarters: Istanbul, Turkey
Key Offering: Composite spunlace fabrics for medical gowns, drapes, and wound care.

With a strong presence in Europe and emerging markets, Mogul has leveraged its regional logistics network to reduce lead times by 25%. The firm’s product portfolio includes antimicrobial‑treated fabrics that meet EN 13795 standards.

Sustainability Initiatives: Implementation of ISO 50001 energy management across all plants.

• R&D focus on incorporating silver nanoparticles for antimicrobial activity.
• Partnership with Turkish Ministry of Health for national wound‑care programs.

5. Ginni Nonwovens Ltd. (India)

Headquarters: Chennai, India
Key Offering: Cost‑effective cotton‑based spunlace for masks and disposable gowns.

Ginni’s low‑cost production model has made it a key supplier for government procurement in India. The company has recently introduced a new line of biodegradable spunlace fabrics for single‑use applications.

Sustainability Initiatives: Use of renewable energy and zero‑waste manufacturing processes.

• Collaborated with Indian Council of Medical Research on wound‑care standards.
• Launched a sustainability certification program for raw‑material suppliers.

6. Unitika Ltd. (Japan)

Headquarters: Tokyo, Japan
Key Offering: Advanced polymer‑fiber spunlace for high‑performance surgical apparel.

Unitika’s expertise in polymer chemistry enables the creation of lightweight, high‑strength fabrics that meet strict sterilization requirements. The company’s recent expansion into the U.S. market includes a new facility in Texas.

Sustainability Initiatives: Implementation of a closed‑loop chemical recycling system.

• Invested in Japan’s Ministry of Environment grants for green manufacturing.
• Developed a proprietary blend of recycled polyester and bio‑polypropylene.

7. Lentex S.A. (Poland)

Headquarters: Warsaw, Poland
Key Offering: Specialty spunlace for medical hygiene and cleanroom applications.

Lentex’s focus on ultra‑clean, particle‑free fabrics has secured contracts with pharmaceutical manufacturers across Europe. The firm has also introduced a new antimicrobial coating for wound dressings.

Sustainability Initiatives: Commitment to carbon neutrality by 2030.

• Partnership with European Union on circular textile initiatives.
• Development of a biodegradable fiber line for disposable products.

8. Novita SA (Greece)

Headquarters: Athens, Greece
Key Offering: High‑quality spunlace for surgical gowns and protective apparel.

Novita’s strategic positioning in the Mediterranean market has allowed it to serve both EU and Middle Eastern customers. The company has recently upgraded its production lines to meet ISO 13485 requirements for medical devices.

Sustainability Initiatives: Adoption of renewable energy sources and waste‑to‑energy projects.

• Collaborated with Greek Ministry of Health on wound‑care guidelines.
• Introduced a line of hemp‑based spunlace fabrics for eco‑conscious markets.

9. Junqian Nonwoven Co., Ltd. (China)

Headquarters: Guangzhou, China
Key Offering: Polyester‑based spunlace for masks and disposable medical textiles.

Junqian’s focus on high‑volume production has positioned it as a leading supplier for the Asia‑Pacific region. The firm has recently increased its output capacity by 40% to support the growing demand for PPE.

Sustainability Initiatives: Implementation of water‑saving technologies in hydroentanglement lines.

• Partnership with Chinese Academy of Sciences on advanced fiber blends.
• Launch of a certification program for sustainable raw materials.

10. Guangdong Guozhen Industrial Co., Ltd. (China)

Headquarters: Shenzhen, China
Key Offering: Polypropylene‑based spunlace for protective gowns and drapes.

Guangdong Guozhen’s rapid expansion into global markets has been driven by its cost‑effective manufacturing model and strong logistics network. The company has recently secured contracts with several U.S. hospital chains.

Sustainability Initiatives: Use of biodegradable additives in spunlace blends.

• Invested in renewable energy projects across Guangdong province.
• Developed a digital traceability system for raw‑material sourcing.

Download FREE Sample Report

Medical Spunlace Nonwoven Fabric Market – View in Detailed Research Report

Get Full Report

Medical Spunlace Nonwoven Fabric Market – View in Detailed Research Report

Market Outlook

The trajectory of the medical spunlace nonwoven fabric market is shaped by a confluence of factors. The escalating need for infection control in hospitals, coupled with the expansion of surgical volumes and outpatient procedure centers, continues to drive demand for high‑performance, single‑use fabrics. Meanwhile, the rise of chronic wound care and advanced dressing technologies creates a premium segment where performance and clinical evidence dominate pricing decisions.

At the same time, the sector faces headwinds from raw‑material price volatility and the capital intensity of hydroentanglement production lines. Regulatory compliance remains a critical lever; manufacturers that can streamline certification processes and achieve multiple international standards will maintain a competitive edge. Sustainability pressures, driven by institutional procurement policies and public‑sector mandates, are prompting a shift toward bio‑based fibers and recyclable solutions.

Future Trends

1. Bio‑Based Fiber Adoption: The move toward cotton, lyocell, and hemp‑derived spunlace will accelerate, driven by patient‑comfort requirements and environmental mandates.

2. Digital Manufacturing: AI‑driven process control and digital twins will reduce fiber loss, lower energy consumption, and enable real‑time quality assurance.

3. Integrated Supply Chains: Regional manufacturing hubs and joint‑venture models will become the norm, especially in emerging markets where local production offers cost and regulatory advantages.

4. Advanced Functional Finishes: Incorporation of antimicrobial, hemostatic, and drug‑delivery layers will create differentiated products that command premium pricing.

Collectively, these trends position the medical spunlace nonwoven fabric market for sustained growth, with significant upside in regions that combine robust healthcare infrastructure with progressive sustainability frameworks.